Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
Mesenchymal Stem Cells Require a Sufficient, Ongoing Immune Response to Exert Their Immunosuppressive Function
Transplantation Proceedings, 09/17/09
Renner P et al. – Mesenchymal stem cells (MSC) have emerged to be one of the most promising candidates for cellular immunotherapy in solid organ transplantation because the reduction of conventional immunosuppression is highly desirable. However, little is known about the details of MSC–mediated immunomodulation and their clinical relevance.
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on vaccination guidelines for allergic children
Expert Review of Vaccines, 10/29/09
Safety of vaccination of patients with systemic lupus erythematosus
Lupus, 11/04/09
Yearly influenza vaccinations: a double-edged sword
The Lancet Infectious Diseases, 11/19/09
Sponsor
Article Search
Sponsor


See Latest Articles


